Statin effects beyond lipid lowering--are they clinically relevant?

Eur Heart J. 2003 Feb;24(3):225-48. doi: 10.1016/s0195-668x(02)00419-0.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Antioxidants / metabolism
  • Apoptosis / physiology
  • Biological Availability
  • Blood Platelets / physiology
  • Cardiomegaly / drug therapy
  • Endothelial Growth Factors / physiology
  • Endothelin-1 / biosynthesis
  • Endothelium, Vascular
  • Fibrinolysis
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hyperlipidemias / blood
  • Hyperlipidemias / prevention & control*
  • Intercellular Signaling Peptides and Proteins / physiology
  • Leukocytes / metabolism
  • Lipids / blood
  • Lymphokines / physiology
  • Macrophage Activation
  • Models, Animal
  • Models, Biological
  • Muscle, Smooth, Vascular / cytology
  • Neovascularization, Pathologic / drug therapy
  • Nitric Oxide / metabolism
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Antioxidants
  • Endothelial Growth Factors
  • Endothelin-1
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Intercellular Signaling Peptides and Proteins
  • Lipids
  • Lymphokines
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Nitric Oxide